硫法洛通过减轻自然杀伤细胞诱导的干细胞阻碍结肠直肠癌
Keshu Hu1, Yu Dong1, Jiayu Zhang1,2
1Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Pharmaceuticals (Basel, Switzerland)
|March 28, 2024
概括
硫法洛逆转了结直肠癌 (CRC) 细胞中自然杀手 (NK) 细胞诱导的干细胞,克服了治疗耐药性. 这表明硫法罗是一种潜在的疗法,可以增强NK细胞介导的免疫监测对CRC.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症干细胞生物学
背景情况:
- 瘤干细胞驱动着结直肠癌 (CRC) 的复发,转移和死亡率.
- 免疫活性细胞,如自然杀手 (NK) 细胞,可以诱导瘤细胞干细胞,导致治疗耐药性.
研究的目的:
- 为了研究NK细胞共同培养对CRC细胞干细胞性的影响.
- 评估硫法罗在逆转NK细胞诱导的CRC的干细胞的疗效.
- 评估硫法罗在克服CRC中的化疗耐药性的潜力.
主要方法:
- 与NK细胞共同培养的CRC细胞系,有或没有硫.
- 在CRC细胞中评估干细胞标记物.
- 化学疗法耐药性测定使用氧沙利和氨酸.
- 使用CRC异种移植模型进行体内评估.
主要成果:
- NK细胞共同培养显著增加了CRC细胞中的干细胞标志物.
- CRC细胞表现出对oxaliplatin和irinotecan后NK细胞共同培养的增强抵抗力.
- 硫法洛在体外和体外模型中有效逆转NK细胞诱导的干细胞.
- 硫法罗在克服化疗耐药性方面表现出有效性.
结论:
- 硫法罗是逆转结肠直肠癌NK细胞诱导的干细胞的一个有前途的药物.
- 硫法洛可以克服与CRCNK细胞激活相关的治疗耐药性.
- 这项研究强调了硫法罗作为一种免疫治疗策略的潜力,以增强NK细胞介导的抗癌免疫力.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K


